Susceptibility to primary biliary cirrhosis (PBC) is strongly associated with human leukocyte antigen (HLA)-region polymorphisms.
INTRODUCTION
The human major histocompatibility complex, human leukocyte antigen (HLA), has been implicated in the etiopathogenesis of primary biliary cirrhosis (PBC), similar to many other autoimmune diseases. Genome-wide association studies (GWAS) of PBC, including our own, find the strongest association with singlenucleotide polymorphisms (SNPs) within the HLA region. [1] [2] [3] In these studies, the peak association signal is between HLA-DQA1 and HLA-DQB1. Multiple studies of PBC also show association with particular classical HLA alleles in PBC (reviewed in Invernizzi 4 ). These studies have variably implicated different DRB1 alleles in the European populations with most studies, including all larger cohorts showing association of DRB1*08. 5, 6 Our previous studies in an Italian cohort with PBC showed the association of DRB1*08 as predisposing, and DRB1*11 and DRB1*13 as protective alleles. 6 A study using a small cohort (32 German PBC cases and 47 controls) suggest that DPB1 associations may also be present in Europeans. 7 However, a comprehensive study of the HLA region associations has not been performed, and like other autoimmune diseases, it is unclear which determinants are actually causally related to pathogenesis.
To further study the HLA associations in PBC, in the current study, we used the most recent advances in imputation algorithms and sequence information resources, including the 1000 genome database to accurately impute missing SNPs, and importantly, HLA classical alleles. Specifically, our investigation rests on recent development and resources for imputing HLA classical alleles, including a reference set of European subjects. 8 For our study, we used an inference set of SNP genotypes from both GWAS and a designed chip array, the Immunochip, 9 which contains a set of SNPs that have been used in multiple studies of HLA. 10 We perform a series of conditioning analyses that clarify which HLA genes and alleles underlie the major component of the genetic associations of PBC.
RESULTS

Analyses show strong association of imputed SNPs and HLA determinants
To further define PBC-HLA region associations, we analyzed association using imputed genotypes with high probabilities and information scores (see Materials and methods). These studies utilized genotypes from both GWAS and Immunochip arrays that contained large numbers of SNPs in the major histocompatibility complex region (Table 1 , Supplementary Table S1 , and see Materials and methods). Strong association was observed with the peak association (P ¼ 9.83 Â 10 À 17 ), with rs115721871 at position 32653792, distal to DQB1 (Figure 1a , Table 2 and Supplementary Table S2 ). Although the strongest associations were with non-coding SNPs, multiple classical genes in HLA show strong association with PBC ( Table 2 ). For the classical HLA genes, the strongest association was with DRB*08 (P ¼ 1.59 Â 10 À 11 ). The DQB1*04:02 and DQA1*04:01 in tight linkage disequilibrium (LD) with DRB*08 (r 2 ¼ 0.84 and 0.89, respectively) showed nearly equivalent signals (1.38 Â 10 À 10 , 1.90 Â 10 À 10 , respectively). Very strong association was also observed for DRB1*11 (P ¼ 1.42 Â 10 À 10) with a weaker association with the DQB1 allele (DQB1*03:01, P ¼ 6.10 Â 10 À 9 ) that is in LD (r 2 ¼ 0.75) with DRB1*11. Less strong associations were observed with DRB1*14, DQB1*05:03 (6.89 Â 10 À 7 and 6.21 Â 10 À 7 , respectively) and DPB1*03:01 (P ¼ 9.18 Â 10 À 7 ). DQB1*05:03 is in nearly complete LD with DRB1*14 (r 2 ¼ 0.97). DPB1*03:01 is not in LD with any of the DRB1, DQB1 or DQA1 classical alleles or amino acids (AAs; r 2 o0.01). There was no association (P410 À 4 ) observed for classical alleles in HLA A, B, C or DPA1.
As expected from the analysis of classical HLA alleles, PBC also showed strong association with specific AAs in these genes. Most of the HLA AA showing association signals corresponded to the key residues that distinguish the specific classical alleles, which for DRB1, included lysine (L) at AA74 in DRB1 (DRB*08), glutamate (E) at AA58 (DRB*11), alanine (A) at AA57 (DRB1*14) and histidine (H) at AA60 (DRB1*14). Similar results were observed for specific DQB1 and DQA1 AAs that are in strong LD with specific DRB1 alleles and AAs ( Supplementary Table S2 ).
Conditioning studies using classical HLA genes To examine whether these associations could be explained for by known coding differences in genes, we next performed a series of conditional analyses. These studies were done by conditioning on a combination of the alleles from an HLA gene (for example, DRB1) to control for the association that might be attributable to each gene, albeit some of the effect may not be directly attributed to that gene because of extensive LD across this region. The residual signals after controlling for the effect of various combinations of classical alleles and AA residues in these HLA genes show that both DRB1 and DQB1 could account for most of the association signal (Figure 1b-e, Table 2 and Supplementary Table S3 ). In addition, the signal in the DPB1 region was only marginally decreased, conditioning on DRB1, DQB1 or DQA1. Conditioning on DPB1 eliminated the signal in the DPB1 region and showed a modest increase in the signal in the across DRB1, DQA1 and DQB1.
To further assess these conditional analyses, we also examined the relative difference of the conditioning by different HLA genes by examining beta estimates and their differences. The beta estimate is the measure of the increase in log-odds that can be attributed to each copy of a given minor allele. The largest effect is from the composite of DRB1 alleles as shown by the residual beta estimates (and odds ratios (ORs)) after conditioning and the mean change in the beta estimates (Table 3 ). This is most evident examining the SNPs with the strongest signals from association (original signalo5 Â 10 À 8 ). For example, the DRB1 conditioning had a much larger mean change in beta estimate ( À 0.424) compared with DQB1 ( À 0.236) (P-value o10 À 10 , paired t-test). Additional conditional analyses using combinations with DQA1 demonstrated that DQA1 could not substitute for DRB1 or DPB1 in any of the combinations tested (data not shown).
Conditioning on specific HLA alleles We next examined the effect of conditioning on specific DRB1, DQA1, DQB1 and DPB1 classical genes and AAs. A clear pattern emerged showing that the association of groups of SNPs was specifically controlled by different alleles. These results are highlighted in Table 4 , and in a more complete version Supplementary Table S3 . Individually, the specific SNPs conditioned a part of the association signal largely corresponding to those SNPs in moderate or strong LD (r 2 40.5) with the particular classical specificity or AA. Similar effects were observed for specific alleles in one gene in strong LD with another gene. This is particularly evident for the DRB1*14 and DQB1*05:03, in which the effects of controlling for either of these alleles was virtually indistinguishable ( Supplementary Table S3 ). Other pairs (for example, DRB1*08 and DQB1*04:02) showed small but consistent differences in which the DRB1 allele diminished more signal than when the DQB1 allele was used in the conditioning analyses ( Supplementary Table S3 ). Notably, the strongest AA association was at position 74 that is in the antigen-binding pocket of DRB1. 11, 12 Similar to when we conditioned on genes ('all' alleles at a particular gene), the DPB1 region SNP signal was only substantially reduced when DPB1*03:01 (Table 4 and Supplementary Table S3 ) or when specific DPB1 AAs were used in conditioning. The strongest effects were observed for the lysine at AA position 11 and the methionine at AA position 76 that are both members of the 16 AA in the putative antigen-binding pocket of this gene. 11 Thus, the vast majority of the HLA region association signal can be accounted individually by conditioning on one of four specific alleles, three in DRB1 (*08, *11, and *14) and one in DPB1 (*03:01). Combinations of these specific alleles accounted for most of the remaining signal ( Supplementary Table S3 and Figure 1f ) and are also reflected in the strong reduction in beta estimates (Table 3) . However, there are signals from several SNPs in the DRB1-DQB1 region that are not accounted for by these conditioning studies. None of these SNPs with signals Po10 À 5 after conditioning on DRB*08, *11 and *14, and DPB1*03:01 were among the stronger associated SNPs before conditioning (all with original association P-values 410 À 6 ). In particular, the strongest associated SNP after conditioning (rs9268668, P ¼ 1.67 Â 10 À 7 ) showed no signal before conditioning (P ¼ 0.40). Whether these residual or new signals are also because of other specific classical HLA genes is not clear; however, conditioning on 'all' DRB1 and DPB1 alleles ablated all signals with resulting P-values410 À 5 (Figure 1f ), suggesting that additional sequence differences (for example, putative regulatory SNPs) do not have to be postulated. Most of the signal observed for specific AAs was also specifically eliminated when conditioning on the DRB1 or DPB1 classical alleles. However, there were several exceptions in which the association signal was not readily decreased by controlling for single classical HLA alleles. These AAs included DRB1-AA47F, DRB1 AA74A, DQB1-AA26G and DQB1-AA74S. For these AAs, the signal was ablated when conditioning on two DRB1 alleles (DRB1*08 and DRB1*11) ( Supplementary Table S3 ). Conversely, conditioning on these AA could not account for the association of the most of the other SNPs that were not ablated by single classical HLA alleles ( Supplementary Table S3 ). Therefore, it may be less likely that these particular AAs are critical to explaining the association patterns we observed. However, we cannot exclude a specific functional role for these AAs, and it is notable that DRB1-AA47 and DRB1-AA74 are both in the antigen-binding pocket of DRB1 11, 12 and that conditioning on DRB1-AA47F did ablate several of the association signals that were not controlled by individual DRB1 classical alleles.
Genotypic associations
We also examined genotypic associations, including combinations of susceptibility alleles, and combinations of risk susceptibility and protective alleles. Examining individuals with combinations of risk alleles, DRB1*08 combined with DPB1*03:01 or DRB1*14 combined with DPB1*03:01, we found higher ORs for disease association than when examining only individuals with single susceptibility alleles ( Supplementary Table S4 ). There were insufficient numbers of DRB1*08/DRB1*14 (frequency o1%) to evaluate these hetero- zygote genotypes. The increased risk of the combining DPB1*03:01 with DRB1*08 or DRB1*14 was observed whether DPB1*0301 was on the same or different haplotype as that of the DRB1 risk allele ( Supplementary Table S4 ). When risk alleles were combined with the DRB1*11 protective allele the ORs were near 1 and there was no significant association with disease.
Finally, we also examined the cumulative combination of risk predisposing and protective alleles ( Table 5 and Supplementary  Table S4 ). The count of predisposing alleles minus protective alleles showed a strong correspondence with the OR for PBC. Individuals with an excess of one or two, or more risk alleles showed an OR of 3.05 and 5.25 between cases and controls, and conversely, individuals with an excess of one or two, or more protective alleles had OR of 0.5 or 0.38, respectively ( Table 5 ). All results were compatible with an additive model of action between each of the alleles similar to our previous observations. 6
DISCUSSION
The current study of PBC association with HLA differs from previous investigations by providing the most comprehensive analysis of the entire HLA region while correcting for multiple confounding factors. Our results are consistent with a predominant role for class II genes and, we believe, exclude any substantial effect from either HLA class I or class III genes (there were no residual signals for these genes with Po0.0005 after accounting for class II genes). This contrasts other autoimmune diseases in which HLA class I or class III has a predominant role (for example, myasthenia gravis 13 ) or strong class I gene effects are observed independent of class II associations for example, type 1 diabetes 14 and multiple sclerosis 15, 16 ).
Our study strongly suggests that the major gene in HLA that underlies susceptibility to PBC is DRB1. Overall, DRB1 alleles show the strongest associations and conditioning studies show that DRB1 could account for almost all (except the DPB1 region) of the association signal. HLA-DQB1 shows association that is only marginally less than that observed for DRB1. However, several points suggest that these associations are secondary to the strong LD between DRB1 and DQB1: (1) the overall strength of association of particular DRB1 alleles is stronger than the corresponding DQB1 allele; (2) conditioning on DRB1 could account for all DQB1 associations; and (3) residual beta-estimates after conditioning showed a substantially stronger DRB1 than DQB1 effect.
In addition, our study provides strong evidence for an independent effect of DPB1. Although previous studies have, as indicated in the introduction, suggested DPB1 associations in PBC, [17] [18] [19] [20] . P-values after conditioning on particular HLA genes (see methods) are also shown. The P-values were determined using SNPTEST V2 (see Materials and methods) and used the genotype probabilities. A complete summary of strongly association markers is provided in Supplementary Table S1 . b The SNP name, classical HLA determinant or AA is shown. c The position corresponding to the marker is shown (chromosomal base pair positions from HG19). d Allele 1 is the minor allele used for the analysis. For sequences designated with AA numbers, the symbol refers to the allele symbol corresponds to standard AA nomenclature. Where the AA is compared with multiple other AAs, 'Other' is used to represent all alternative AAs. The AA position includes the leader sequence (for example, DRB1* position 104 is the same as AA position 74 without the leader sequence). Where HLA determinants are provided, the specificity is compared with not having the specificity (OTHER). e MAF were estimated from probabilities (SNPTEST V2). f P-values before conditioning using population substructure and gender as covariates. g P-value after conditioning on the allele(s) listed in the heading line.
these were based on small subject sets and were difficult to evaluate. Our study demonstrates that the association of DPB1 cannot be accounted for by controlling for other HLA region genes. These results are also consistent with findings in some, but not other, autoimmune diseases in which an independent effect of DPB1 has been reported. These include juvenile idiopathic arthritis, 17 type 1 diabetes, 18 multiple sclerosis 16, 19 and particular autoantibodies in systemic lupus erythematosus. 20 Abbreviations: AA, amino acid; Cond., conditioning; HLA, human leukocyte antigen; OR, odds ratio; SNP, single-nucleotide polymorphism. a The group corresponds to those markers that are successfully controlled by specific HLA alleles (P-value after conditioning is 41 Â 10-4. The bold highlighted P-values indicate the P-values used in the 'group' assignment. For each group, the following are shown in this abbreviated summary: i) the two SNPs with the strongest association in the group; ii) the two HLA AA with the strongest association; and iii) all classical HLA alleles with Po10-6 before conditioning. The P-values were determined using SNPTEST V2 (see methods) and used the genotype probabilities. A more complete summary of strongly association markers is provided in Supplementary Table S2 . b The SNP name, classical HLA determinant or AA is shown. For the AA, the letter following the residue number provides the relevant AA. c The position corresponding to the marker is shown (chromosomal base pair positions from HG19). d P-values after conditioning using population substructure and gender as covariates. e P-values after Cond on the allele(s) listed in the heading line. We note that our study does not directly address whether DRB3, DRB4, DRB5 or structural variations might have additional independent associations. At present, such studies are challenging because of absence of reference sets for imputation and/or difficulty in assessing these polymorphisms, including whether missing genotypes (excluded SNPs with call rates o0. 95) may have excluded analysis or inclusion of SNPs within these genes in available arrays.
This study has also addressed the association of specific HLAgene alleles. Most of the HLA association with PBC can be attributed to specific associations with DRB1*08, DRB1*11, DRB1*14 and DPB1*03:01. DRB1*08 has the strongest association, followed by DRB1*11, consistent with several previous studies. 6, 7 PBC associations with DRB1*14 has not been previously demonstrated; however, this weaker effect is supported by our conditioning studies that show that this classical allele can control for a set of associated SNPs and AAs that are not strongly influenced by other classical alleles (Table 3 and Supplementary  Table S3 ). The DPB1*0301 association is consistent with a previous study of a small German cohort. 7 In a previous study, we observed that DRB1*13 was a protective allele. 6 In the current study, the association of DRB1*13 was weak (P ¼ 4.9 Â 10 À 3 , OR¼ 0.69, 95% confidence limits ¼ 0.53-0.89) compared with the previous study (P ¼ 3.6 Â 10 À 6 ). This may be because of several factors: (1) the previous study did not explicitly control for population substructure; (2) the overlap of subjects with the previous study iso25% and the difference may reflect statistical noise; and (3) the previous study used DNA typing rather than the imputation used in the current study. It may be worth noting that DRB1*13 like DRB1*11 has an alanine at AA position 74 and thus contributes to the protective effect observed for this AA (P ¼ 1.33 Â 10 À 11 , Supplementary Table S3 ). Similarly, our previous study 6 showed only a marginal association of DRB1*14 (uncorrected P-value ¼ 0.004) compared with a strong association (P ¼ 6.9 Â 10 À 7 ) observed in our current study. Here, the conditioning study results, including the effect of controlling SNPs with very strong associations (see group 3, Table 4 ), provide additional support for the role of DRB1*14.
Finally, we have also considered specific HLA AAs. Most of the associated AAs are both nearly unique to the specific HLA classical alleles discussed above and also correspond to critical residues for the antigen-binding pocket. Thus, associated AAs in DRB1 at AA positions 37, 47, 57, 60, 67, 70 and 74; and DPB1 at AA positions 9, 11, 76, 84, 87 are antigen-pocket AAs. 11, 12 Consistent with our results, strong associations have been recently observed with serine at position 57 and leucine at position 74 in a Japanese PBC cohort. 21 We also note that many of the associated DQB1 AAs are also in critical residues for antigen binding (DQB1-AA13, 26, 70, 71, 74). 11, 12 Of the DRB1 associated, only AA58 is not among the AAs in this functional class, whereas for DQB1, several are not in this functional class (DQB1-AA45, 56, 75, 167, 185) .
In conclusion, the most parsimonious explanation consistent with the current study is that classical HLA genes and the coding variations within these genes are responsible for the HLA associations with PBC. Although we cannot exclude the possibility that other sequence variations affecting, for example, gene regulation could be important, our data indicates that a limited set of classical DRB1 and DPB1 alleles are sufficient to explain the HLA associations with this disease. We believe the current data provides cogent information for understanding HLA-associations in PBC. Studies in other ethnic groups both within Europe and in other continental groups will also be important in further definition of the role of particular HLA genes and alleles. Lastly, our results provide additional rational for functional studies examining specific HLA genes and their relative binding to the putative disease-associated epitopes of the PDC-E2, the immunodominant autoantigen epitopes of PBC. 22, 23 
MATERIALS AND METHODS
Study population and design
The Italian PBC cases were obtained through a multi-center study and met internationally accepted criteria for the diagnosis of PBC as detailed in a previous study. 6 Each of the included cases also met ancestry criteria as defined below (see Ancestry). Controls were derived from several sources and this sample set information is detailed in Supplementary Table S1 . After data filtering and ancestry, analyses contained 676 Italian PBC cases and 1440 Italian controls. All subjects enrolled in the study provided written informed consent and the study followed ethical guidelines of the most recent revision of the Declaration of Helsinki (Edinburgh, 2000) .
All samples were genotyped with either Illumina (San Diego, CA, USA) genome-wide and/or Immunochip SNP platforms, and the participants included the data set from our previous GWAS as well as new samples (see Supplementary Table S1 ). With the exception of ancestry information and assessment of relatedness, the current study was restricted to genotypes in an approximately 4 Mb segment of human chromosome 6 (bps 28911802-33813043, HG19 map). This data set comprised a minimum of 1548 and a maximum of 5489 genotyped SNPs in each individual ( Supplementary Table S1 ) and was used for the SNP and HLA imputations (see Imputation).
Data filtering
We used stringent quality-control criteria to ensure that high-quality data were included in the analyses. We excluded individuals who had 45% missing data, and all individuals with cryptic relatedness and duplicate samples based on identity-by-descent status for genome-wide SNPs (PI^40.15) using PLINK. 24 We included only SNPs with o5% missing data, Hard--Weinberg equilibrium P-values 410 À 4 in controls and 410 À 5 in combined cases and controls (to exclude most genotyping errors), applying these procedures in a stepwise approach separately for each data set. For each of the separately derived control genotyping sets ( Supplementary Table  S1 ), SNPs were excluded if they failed the above criteria within the individual control set or in combination with any of the other control groups, or in the complete data set. The Hard-Weinberg criteria were applied after exclusion of non-European individuals (see Ancestry). Finally, SNPs were excluded if allele frequency differed by 410% between different control subject groups. 
Ancestry
European ancestry was determined using 883 genome-wide SNPs with minimal or no LD (r 2 o0.1). SNPs analyzed using the STRUCTURE v2.1 program 25 and subjects of known European, Amerindian, East Asian and West African origin as previously described. 26 We used STRUCTURE to exclude non-European and admixed study participants, as this method allows exclusion/inclusion criteria to be set using reference populations. Subjects with 415% non-European ancestry were excluded from further analysis. Italian ancestry was defined using principal components (PCs) analyses. For subjects with GWAS data, we used the same methods and criteria applied in a previous study with largely the same data set. Briefly, PCs analyses was performed using the EIGENSOFT statistical package, 27 utilizing 34 000 SNPs distributed throughout the genome (r 2 o0.1) that we have previously used to define population genetic substructure. 2 These analyses used an independent set of Italian subjects for establishing membership ( ± 2 s.d.) in first four PCs). In the current study, a substantial portion of the samples did not have GWAS data ( Supplementary Table S1 ). For these samples, we used a set of 12 579 SNPs from the Immunochip for which our empiric analyses demonstrated the ability of this set to discern Italian ancestry and exclude both the other European ethnicities, including Sardinian Italians (Supplementary Figure S1 ). Using the GWAS-defined individuals, the Immunochip only genotyped samples were included using 2 s.d. in the first four PCs. In addition to the subject selection, we used the eigenvalues from the first four PCs (only the first four PCs were significant based on Tracy-Widom statistics) as covariates in our association analyses.
Imputation
We imputed SNPs, HLA classical alleles and HLA gene AAs using phased reference genotypes from both the 1000 genome-sequencing project (interim release June 2011) (http://www.1000genomes.org/) and an HLAdefined reference set. 8 For the 1000 genome imputation, we used IMPUTE version 2 28 under default parameters. The reference haplotypes for this imputation were from 1094 subjects, including 381 European subjects and 98 Tuscan Italians. The number of genotyped (inference) SNPs that overlapped with the 1000 genome reference set ranged from 1435 SNPs (samples typed by GWAS), 4386 (samples typed by Immunochip) to 4981 SNPs (samples typed by GWAS plus Immunochip) ( Supplementary Table  S1 ). For subsequent data analyses, we utilized only imputed genotypes with maximum posterior probability scores of 40.90. Using this parameter, our empiric testing (leave one-out analyses) indicated that the maximum error rate for genotype assignment was o0.05, and the mean error rate was o0.01. To impute classical HLA alleles and corresponding AAs determinants, we utilized a reference separate data set of collected by the Type 1 Diabetes Genetics Consortium. This reference data contains genotype data for 2537 SNPs, selected to tag the entire major histocompatibility complex, and classical types for HLA-A, B, C, DRB1, DQA1, DQB1, DPA1 and DPB1 at 4-digit resolution in 2767 unrelated individuals of European descent. 29 The Beagle software package 30 was used for this imputation under default parameters. The number of inference SNPs that overlapped with this reference data set ranged from 648 (samples typed by GWAS), 1444 SNPs (samples typed by Immunochip) to 1610 SNPs (GWAS plus Immunochip) ( Supplementary Table S1 ). Similar to the imputation using 1000 Genome data, only SNPs with posterior probabilities of 40.90 were included in our final analyses. For imputed SNPs that overlapped between the two imputation sets and algorithms used (Impute V2.0 and Beagle), there was a nearly complete concordance of the association-testing results, indicating similar performance of these algorithms for this data set. After imputation and selecting only those markers meeting posterior probability criterion, this region contained a total of 49 885 markers including the genotyped SNPs that were included in association test analyses.
Association and conditional association tests of imputed SNPs and HLA determinants SNPTEST V2.0 28 (web) was used for the primary association analyses for the imputed genotypes. This software uses the genotype probabilities for the imputed SNPs or determinants and accounts for genotype uncertainty. The first four PC eigenvalue scores were used as continuous variables in the association test together with the gender covariate. Analyses were performed using the SNPTEST v2 Score test algorithm that enabled both the inclusion of the covariates and conditioning tests, and all of our reported results used an additive model. To minimize potential spurious results, we limited our main and conditioning analyses to markers with information scores (Inf)40.85. This parameter is a measure of the observed statistical information for the estimate of SNP allele frequency (for additional information see https://mathgen.stats.ox.ac.uk/genetics_software/ snptest/snptest.v2.pdf).
Conditioning on multiple markers either separately or together was performed using an additive model. For the HLA region, over 150 conditional analyses were performed using the SNPs and HLA determinants, including all HLA determinants with P-values o10 À 6 .
Nominal P-values after correction for covariates and conditioning are provided throughout the manuscript. The P-values o10 À 6 would remain significant after conservative (Bonferroni) correction for the number of markers (o50 000) tested after imputation.
